This mutation has been previously described in unrelated patients with IGHD from Sergipe/Brazil, Pakistan, Spain and the United States, and has been reported to lead to reduced cAMP production after GHRH stimulation with normal cell- surface localization of the receptor, suggesting a defect in ligand binding (14). This evidence concerns the gene GHRH and isolated congenital growth hormone deficiency.